Dolutegravir rollout for treatment of HIV with a focus on advanced disease and tuberculosis coinfection: findings from rural KwaZulu-Natal, South Africa (2019–2023)
Our analysis showed that over a quarter of the PLHIV in rural KZN remained on non-DTG-containing regimens by 31st December 2023. PLHIV coinfected with TB and having AHD transitioned at a slower pace than their counterparts.
Authors
- Larisse Bolton (ORCID: https://orcid.org/0000-0001-7879-2173)
- Peter S. Nyasulu (ORCID: https://orcid.org/0000-0003-2757-0663)
- Elphas Luchemo Okango (ORCID: https://orcid.org/0000-0002-4159-9588)
- Markus Otto (ORCID: https://orcid.org/0000-0003-4273-4267)
- Reuben Christopher Moyo (ORCID: https://orcid.org/0000-0003-4308-0103)
- Frank Tanser (ORCID: https://orcid.org/0000-0001-9797-0000)
- Nthoesele Letoao
Institutions
- Stellenbosch University (ZA)
- Africa Health Research Institute (ZA)
Publication Details
- Journal
- AIDS Research and Therapy
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1186/s12981-025-00810-z
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- South African Medical Research Council
- Deutsche Forschungsgemeinschaft
- Medical Research Council
- National Institute of Mental Health